The University of Pittsburgh Department of Medicine is a formidable leader in cutting-edge research. Our basic scientists, clinical researchers, and clinicians work daily to make research discoveries that will positively impact the world’s healthcare.
Dr. Dimitrov was one of ten researchers awarded with this distinction by MediFind based on his discovery of potent, neutralizing monoclonal SARS-CoV-2 antibodies as part of the U.S. COVID-19 response.
We are confident that Dr. Ascherman’s strengths across the tripartite mission and his proven administrative acumen will enable the Division to continue to grow and flourish under his leadership.
Given that the research mission of the Department of Medicine and the development and sustainment of the career development pipeline remain central tenants of our academic vision, it is our pleasure to announce the appointment of Oliver Eickelberg, MD, as Vice Chair for Basic and Translational Research.